Finally Some Good News as the FDA Lifts Hold on Sanofi, Alnylam's Fitusiran Post author:Sam Post published:December 14, 2017 Post category:BioPharma Clinical trial dosing will resume around year-end 2017. Source: BioSpace You Might Also Like AstraZeneca's Three-in-One COPD Inhaler Succeeds in Phase III Trial January 25, 2018 FDA Hails Novartis' Kisqali a Breakthrough January 2, 2018 Here???s Where Jobs in Shrinking Life Sciences Marketing Departments Are Headed February 19, 2017
